Gaines Kristin Sallee 4
4 · NATIONAL HEALTH INVESTORS INC · Filed Mar 5, 2025
Insider Transaction Report
Form 4
Gaines Kristin Sallee
SVP/Chief Transaction Officer
Transactions
- Award
Common Stock
2025-03-03+4,000→ 61,944 total - Award
Stock Option (Right to Buy) 2025
2025-03-03+8,333→ 8,333 totalExercise: $73.34From: 2026-03-03Exp: 2030-03-03→ Common Stock (8,333 underlying) - Award
Stock Option (Right to Buy) 2025
2025-03-03+8,334→ 8,334 totalExercise: $73.34From: 2027-03-03Exp: 2030-03-03→ Common Stock (8,334 underlying) - Award
Stock Option (Right to Buy) 2025
2025-03-03+8,333→ 8,333 totalExercise: $73.34From: 2025-03-03Exp: 2030-03-03→ Common Stock (8,333 underlying)
Holdings
- 18,333
Stock Option (Right to buy) 2022
Exercise: $53.41From: 2022-02-25Exp: 2027-02-25→ Common Stock (18,333 underlying) - 18,334
Stock Option (Right to buy) 2022
Exercise: $53.41From: 2024-02-25Exp: 2027-02-25→ Common Stock (18,334 underlying) - 8,333
Stock Option (Right to Buy) 2023
Exercise: $54.73From: 2024-02-24Exp: 2028-02-24→ Common Stock (8,333 underlying) - 8,333
Stock Option (Right to Buy) 2024
Exercise: $57.76From: 2024-02-23Exp: 2029-02-23→ Common Stock (8,333 underlying) - 18,333
Stock Option (Right to buy) 2022
Exercise: $53.41From: 2023-02-25Exp: 2027-02-25→ Common Stock (18,333 underlying) - 8,333
Stock Option (Right to Buy) 2023
Exercise: $54.73From: 2023-02-24Exp: 2028-02-24→ Common Stock (8,333 underlying) - 8,334
Stock Option (Right to Buy) 2023
Exercise: $54.73From: 2025-02-24Exp: 2028-02-24→ Common Stock (8,334 underlying) - 8,333
Stock Option (Right to Buy) 2024
Exercise: $57.76From: 2025-02-23Exp: 2029-02-23→ Common Stock (8,333 underlying) - 8,334
Stock Option (Right to Buy) 2024
Exercise: $57.76From: 2026-02-23Exp: 2029-02-23→ Common Stock (8,334 underlying)
Footnotes (1)
- [F1]These shares are restricted stock which vest 20% on each anniversary of the date of grant, starting March 3, 2026